Alexza Pharmaceuticals (ALXA) Tops Q2 EPS by 4c
More News related to ALXA
- Unusual 11 Mid-Day Movers 6/16: VOXW, ALXA, STEC, EMKR Higher; MTXX, AHT, SURG, ANCI Lower
- Alexza (ALXA) Surges On Symphony Deal, Analyst Still Sees A Near-Double In Price
- Notable Mergers and Acquisitions of the Day 6/16: ALXA, PG
- Morning Movers 6/16: VOXW, EMKR, LZB, HOV, ALVR, MRNA Higher; SURG, AHT, FCEL Lower
- Alexza Pharma (ALXA) Exercises Option to Purchase All Equity of Symphony Allegro
Alexza Pharmaceuticals (Nasdaq: ALXA) reports a Q2 loss of $0.43, 4 cents better than the analyst estimate of ($0.47). No revenues were reported for the quarter.
Related Categories
EarningsStocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
